ClinicalTrials.Veeva

Menu

Efficacy and Safety of Ivabradine to Reduce Heart Rate Prior to Coronary CT-angiography in Advanced Heart Failure: Comparison With β-Blocker

R

Rajaie Cardiovascular Medical and Research Center

Status

Unknown

Conditions

Heart Rate Low
Heart Failure, Diastolic
Heart Failure, Systolic
CT Angiography
Heart Failure
Non-ischemic Cardiomyopathy
Heart Failure,Congestive
Ischemic Cardiomyopathy

Treatments

Drug: Ivabradine
Drug: Metoprolol

Study type

Interventional

Funder types

Other

Identifiers

NCT03830957
HFRC_01

Details and patient eligibility

About

The aim of this study is to compare the effects of Ivabradine and metoprolol to reduce heart rate prior to coronary CT angiography in patients with advanced heart failure.

Enrollment

200 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Sinus rhythm
  • Heart rate >60/min

Exclusion criteria

  • Atrial fibrillation
  • Any contraindication for beta-blocker use

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

200 participants in 2 patient groups

Ivabradine
Active Comparator group
Treatment:
Drug: Ivabradine
metoprolol
Active Comparator group
Treatment:
Drug: Metoprolol

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems